Erik Esper
Family Medicine · Erie, PANPI 1093796625
Payments from drug & device makers
Across 189 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$576
- Novo Nordisk$307
- Johnson & Johnson$288
- Lilly USA, LLC$250
- AstraZeneca$234
- Boehringer Ingelheim$231
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,19899%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 8 | $576 |
| Novo Nordisk | 19 | $307 |
| Johnson & Johnson | 22 | $288 |
| Lilly USA, LLC | 17 | $250 |
| AstraZeneca | 16 | $234 |
| Boehringer Ingelheim | 16 | $231 |
| Pfizer | 22 | $203 |
| AbbVie(2 entities) | 9 | $159 |
| GSK | 11 | $149 |
| Novartis | 8 | $146 |
| Merck | 8 | $115 |
| Bayer | 5 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $87 |
| Amgen | 5 | $77 |
| Astellas Pharma US Inc | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 4 | $58 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $34 |
| Madrigal Pharmaceuticals | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $11 |
| Corcept Therapeutics | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,219 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 15 | $273 |
| Metoprolol Succinate | 12 | $234 |
| ClopidogrelClopidogrel Bisulfate | 16 | $213 |
| Potassium Chloride | 16 | $84 |
| Hydralazine Hcl | 11 | $83 |
| Gabapentin | 13 | $68 |
| Metformin Hcl ErMetformin Hcl | 19 | $61 |
| Amlodipine Besylate | 28 | $40 |
| Allopurinol | 15 | $35 |
| Losartan Potassium | 11 | $32 |
| Atorvastatin Calcium | 12 | $30 |
| Furosemide | 13 | $28 |
| Atenolol | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Erie
- Bruce GebhardtErie$2.1M
- Bradley FoxErie$1.7M
- Jack YakishErie$86K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.